Product List Page 4374

Product ID Product Name CAS# Purity    Y3288046 PTPN2/1-IN-2 2407611-02-1  98% Y3298083 PB089 2892336-54-6  99% Y3288732 BLU0588 2810747-78-3  95% Y3296393 STAT6-IN-3 371919-80-1  95% Y3297951 RTIOXA-43 2832067-72-6  99% Y3293587 Anti-NASH agent 1 2409685-41-0  98% Y3295631 GPX4-IN-6 2922824-07-3  95% Y3286343 FDW028 2768426-49-7  99% Y3294954 AJ2-71 2700323-17-5  99% Y3308540 YG1702 724737-08-0  99% Y3292445 ERK5-IN-5 2318792-30-0  99% Y3290548 TINK-IN-1 1417795-25-5  98% Y3297050 WRN inhibitor 4 2923009-45-2  99% Y3287874 GPR88 agonist 2 2821859-71-4  99% Y3296417 AEF0117 1610878-71-1  95% Y3297943 Exatecan-methylacetamide-OH 2594423-51-3  97% Y3307919 LU-002i 1838705-22-8  99% Y3293838 NPR-C activator 1 2768328-61-4  99% Y3286465 PAK4-IN-2 2488706-33-6  99% Y3292373 RBP4 inhibitor 1 1198180-03-8  99% Y3295112 Galectin-3-IN-1 1989627-40-8  99% Y3290187 Onradivir 2200336-20-3  99% Y3307461 LSD1-IN-20 1239589-91-3  98% Y3304955 a-Glucosidase-IN-4 2410538-67-7  99% Y3290227 DFBTA 2966044-07-3  98% Y3311364 PARP1/2/TNKS1/2-IN-1 2243453-32-7  98% Y3310533 LLO (190-201) 331941-87-8  98% Y3309165 DYRKtide 2250228-51-2  98% Y3288273 DSPE-NHS 1383932-86-2  95% Y3294123 HDAC6-IN-26 2991427-19-9  99% Y3289881 2-Methanesulfonamido-1,3-thiazole-5-carboxylic acid 960324-88-3  95% Y3314471 9,10-Dihydro-9,10[1′,2′]-benzenoanthracen-2-amine 31997-11-2  95%+ Y3316135 (S)-2-(3-(4-(tert-Butoxy)phenyl)-2-((tert-butoxycarbonyl)amino)propanamido)-2-methylpropanoic acid 2639221-78-4  95% Y3305662 2-[(tert-butoxy)carbonyl]-2-azabicyclo[2.2.1]hept-5-ene-3-carboxylic acid 2168730-48-9  95% Y3311305 2-(1,1-difluoroethyl)benzene-1-sulfonamide 2580250-93-5  95% Y3310262 (4S,5R)-3-{[(9H-fluoren-9-yl)methoxy]carbonyl}-2,2,5-trimethyl-1,3-oxazolidine-4-carboxylic acid 2023823-19-8  95% Y3308576 tert-butyl N-[1-(1-hydroxyethyl)cyclopropyl]carbamate 1889529-26-3  95% Y3293165 6-{[(9H-fluoren-9-yl)methoxy]carbonyl}-1-methyl-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridine-3-carboxylic acid 2171982-01-5  95% Y3286432 N-Hexadecyl-N-methylbenzenemethanamine 47461-80-3  95% Y3248933 3-bromo-2-(4-bromo-1H-pyrazol-1-yl)propan-1-ol 2919955-11-4  95% Y3313952 [(1H-indazol-7-yl)methyl](methyl)amine 1520346-89-7  97% Y3289410 [1-(cyclopentylamino)cyclopentyl]methanol 285124-30-3  95% Y3288230 2-Chloro-1-[3-nitro-4-(phenylmethoxy)phenyl]ethanone 871266-45-4  95% Y3179064 Deflazacort-d3 2280940-17-0  95% Y3179065 LSD1-IN-30 1289575-45-6  99% Y3171592 Cholesteryl-Teg azide 1391826-58-6  95% Y3181139 Ferroptosis-IN-6 1517780-59-4  98% Y3181140 SHEN26 2691076-98-7  99% Y3305672 MAO-B-IN-5 849909-77-9  95% Y3308648 Acetic acid, 2-[4-[(2-ethyl-3-benzofuranyl)carbonyl]phenoxy]- 91627-33-7  100% Y3306650 11ß-HSD1 inibitor 19 946400-19-7  99% Y3306450 EB1 42951-68-8  99% Y3304780 mTOR inhibitor 9a 1144075-32-0  99% Y3293465 TDO-IN-1 2490672-92-7  99% Y3311202 (Iso)-Fosdevirine 2869918-45-4  100% Y3304704 Human PD-L1 inhibitor V 2815311-61-4  99% Y3296915 4-[2-[4-[1-(2-Hydroxyethyl)-1H-benzimidazol-2-yl]-1-piperidinyl]ethyl]-a,a-dimethylbenzeneacetic Acid 202189-83-1  95% Y3307712 Piperazine, 1-(4-fluorophenyl)-4-[(3,4,5-trimethoxyphenyl)methyl]- 80305-11-9  99% Y3306081 3-(7,7-dimethyl-5-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyridin-2-yl)-1H-indole-7-carbonitrile 2759137-87-4  98% Y3308826 hCAII-IN-9 2878477-18-8  98% Y3311636 Mequitamium 101396-46-7  98% Y3306993 (R)-Naroparcil 252647-51-1  97% Y3308269 PF-17 2697145-21-2  100% Y3304773 Alalevonadifloxacin 2892364-59-7  100% Y3307195 Aß-IN-1 2766509-32-2  99% Y3310850 Cap-dependent endonuclease-IN-1 2365473-17-0  98% Y3310489 mTOR inhibitor 9f 1144075-42-2  98% Y3306302 (S)-ABT 102 808756-70-9  99% Y3293961 L2H2-6OTD intermediate-2 890403-75-5  99% Y3292081 Glucocorticoid receptor agonist-1 phosphate Gly-Glu-Mal 2345732-83-2  99% Y3290547 L2H2-6OTD intermediate-1 912656-47-4  98% Y3295542 Gly-Gly-Gly-PEG2-azide 2222277-20-3  95% Y3287034 TDP-43 degrader-1 2902692-25-3  95% Y3309205 MTX115325 2750895-97-5  99% Y3318216 4-Chloro-3-fluoro-5-methylbenzoic acid 1427418-68-5  97% Y3289206 AK-2292 2984506-77-4  98% Y3295050 GLP-1R agonist 10 2762515-25-1  98% Y3297400 ß-catenin-IN-4 2353536-67-9  99% Y3289668 SMTIN-T140 2851532-40-4  99% Y3291273 Sonrotoclax 2383086-06-2  99% Y3293364 STING-IN-6 2305940-34-3  98% Y3292728 Werner syndrome RecQ helicase-IN-4 2869954-53-8  98% Y3295029 TIM-063 2493978-38-2  95% Y3287343 PCSK9-IN-13 2244129-23-3  98% Y3308452 GPR139 agonist-2 2983118-29-0  99% Y3288189 TMDJ-035 2681302-83-8  99% Y3298142 BMS-684 313552-29-3  99% Y3307305 ABBV-467 2287186-66-5  99% Y3306754 HIF-1a-IN-5 2826221-10-5  99% Y3294699 STAT3-SH2 domain inhibitor 1 2816059-41-1  98% Y3290427 CYP4A11/CYP4F2-IN-1 502654-40-2  95% Y3297122 Anticancer agent 93 94205-22-8  98% Y3310472 MC2590 2284460-01-9  99% Y3304865 WRN inhibitor 1 2923008-44-8  98% Y3291610 PI5P4K-IN-1 2419358-87-3  95% Y3307576 MMP-9-IN-7 333746-76-2  97% Y3290048 TCRS-417 2032123-28-5  95% Y3309067 BChE-IN-17 2425632-57-9  99% Y3287677 AChE/BuChE-IN-4 1997158-25-4  99% Y3305505 Tubulin polymerization-IN-55 2942396-29-2  98%